SCHEMBL2239807

SCHEMBL2239807

COc1ccc(OS(=O)(=O)c2cccc([N+](=O)[O-])c2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.59
MEN1 O00255 3/20 0.59
L3MBTL1 Q9Y468 2/20 0.59
MAPK1 P28482 1/20 0.56
HTT P42858 3/20 0.55
GAA P10253 2/20 0.55
NFE2L2 Q16236 1/20 0.55
GPR17 Q13304 1/20 0.54
CA2 P00918 1/20 0.53
CA5A P35218 1/20 0.53
ALDH1A1 P00352 2/20 0.52
ALPL P05186 1/20 0.52
ALPI P09923 1/20 0.52
LMNA P02545 3/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
TDP1 Q9NUW8 1/20 0.51
MAPT P10636 3/20 0.51
POLB P06746 2/20 0.51
F2 P00734 2/20 0.51
HPGD P15428 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27264924 0.88 KMT2A (0.59) KMT2AMEN1HTTGAAGPR17
SCHEMBL27464615 0.87 KMT2A (0.60) KMT2AMEN1HTTGAAGPR17
SCHEMBL16396322 0.85 KMT2A (0.73) KMT2AMEN1L3MBTL1MAPK1HTT
SCHEMBL2239838 0.85 KMT2A (0.51) KMT2AMEN1MAPK1HTTGAA
SCHEMBL2236729 0.84 KMT2A (0.50) KMT2AMEN1L3MBTL1HTTGAA
SCHEMBL2237370 0.83 ALDH1A1 (0.63) L3MBTL1HTTGAACA2CA5A
SCHEMBL2239682 0.83 ALDH1A1 (0.63) L3MBTL1HTTGAACA2CA5A
SCHEMBL8818922 0.82 GPR17 (0.65) KMT2AHTTGAAGPR17CA2
SCHEMBL8820307 0.82 KMT2A (0.56) KMT2AMEN1L3MBTL1HTTGAA
SCHEMBL1317032 0.82 KMT2A (0.66) KMT2AMEN1L3MBTL1HTTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9034888-B2 Substituted 2-imidazolidones and analogs UNIVERSITE LAVAL (CA) 2015-05-19 US disclosed
US-9034888-B2 Substituted 2-imidazolidones and analogs UNIVERSITE LAVAL (CA) 2015-05-19 US disclosed
US-9034888-B2 Substituted 2-imidazolidones and analogs UNIVERSITE LAVAL (CA) 2015-05-19 US disclosed
EP-2536693-A1 SUBSTITUTED 2-IMIDAZOLIDONES AND ANALOGS Université Laval (CA) 2012-12-26 EP disclosed
US-20120309777-A1 SUBSTITUTED 2-IMIDAZOLIDONES AND ANALOGS UNIVERSITE LAVAL (CA) 2012-12-06 US disclosed
US-20120309777-A1 SUBSTITUTED 2-IMIDAZOLIDONES AND ANALOGS UNIVERSITE LAVAL (CA) 2012-12-06 US disclosed
US-20120309777-A1 SUBSTITUTED 2-IMIDAZOLIDONES AND ANALOGS UNIVERSITE LAVAL (CA) 2012-12-06 US disclosed
WO-2012142698-A1 ALKYLUREA DERIVATIVES ACTIVE AGAINST CANCER CELLS UNIVERSITE LAVAL (CA) 2012-10-26 WO disclosed
WO-2011100840-A1 SUBSTITUTED 2-IMIDAZOLIDONES AND ANALOGS UNIVERSITé LAVAL (CA) 2011-08-25 WO disclosed
WO-1997048677-A1 NON-IONIC PHOTOACID GENERATORS WITH IMPROVED QUANTUM EFFICIENCY PPG INDUSTRIES, INC. (US) 1997-12-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120309777-A1 SUBSTITUTED 2-IMIDAZOLIDONES AND ANALOGS CCNY, RPS4Y1, TPX2 KMT2A 1452/4885MEN1 1673/4885L3MBTL1 1374/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.